Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

COVID-19: Answering the Questions, Part 5

Source: COVID-19 Comprehensive Resource Center
In Part 5 of this ongoing 12-part COVID-19 series, listen to a brief update on the epidemiology of SARS-CoV-2 and evidence-based interventions for reducing transmission, followed by answers to critical clinician questions on COVID-19 transmission and mitigation by David Heymann, BA, MD, DTM&H.
David Heymann, BA, MD, DTM&H
Released: September 2, 2020

In this episode, Part 5 of an ongoing 12-part COVID-19 series, David Heymann, BA, MD, DTM&H, provides a brief update on the epidemiology of SARS-CoV-2 and evidence-based interventions for reducing transmission,. After the update, Professor Heymann answers critical clinician questions on COVID-19 transmission and mitigation.

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Link to full program: https://www.clinicaloptions.com/infectious-disease/programs/covid19-resources

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by
Gilead Sciences, Inc.

Related Content

Download free slides from CCO reviewing the latest updates on COVID-19 epidemiology and emerging data on diagnosis and transmission

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Roger Paredes, MD, PhD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: March 26, 2021

Download free slides from CCO reviewing the latest data and guidance on COVID-19 treatments, including authorized and investigational agents

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Roger Paredes, MD, PhD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: March 26, 2021

Download free slides from CCO reviewing the latest data and guidance on COVID-19 symptoms and the prevalence and duration of natural immunity

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Roger Paredes, MD, PhD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: March 26, 2021

Download free slides from CCO reviewing the latest data and guidance on COVID-19 risk and management in special populations and persons with comorbidities

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Roger Paredes, MD, PhD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: March 26, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue